Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants

Neonatology

Volumn 103, Issue 3, 2013, Pages 166-169

  Oncel, Mehmet Yekta ^a   Yurttutan, Sadik ^a   Degirmencioglu, Halil ^a   Uras, Nurdan ^a   Altug, Nahide ^a   Erdeve, Omer ^a   Dilmen, Ugur ^a,b  

^a ANKARA UNIVERSITY   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Intravenous; Paracetamol; Patent ductus arteriosus; Preterm infant

Indexed keywords

PARACETAMOL;

ABSENCE OF SIDE EFFECTS; AORTA ROOT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; DRUG EFFICACY; ECHOCARDIOGRAPHY; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; HEART LEFT ATRIUM; HUMAN; NEWBORN; PARENTAL CONSENT; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL;

EID: 84876146935     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000345337     Document Type: Article

References (16)

1. Noori S: Patent ductus arteriosus in the preterm infant: to treat or not to treat? J Perinatol 2010; 30: 31-37.
2. Hermes-DeSantis ER, Clymann RI: Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006; 26: 14-18.
3. Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, Oguz SS, Uras N: Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2012; 97: 279-283.
4. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U: Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 2011; 158: 549-554.
5. Neumann R, Schulzke SM, Bührer C: Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology 2012; 102: 9-15.
6. Erdeve O, Yurttutan S, Ozdemir R, Dilmen U: Oral ibuprofen for treatment of patent ductus arteriosus: more than a cheap alternative? Neonatology 2012; 102: 196.
7. Zecca E, Romagnoli C, De Carolis M, Costa S, Marra R, De Luca D: Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics 2009; 124: 480-484.
8. Erdeve O, Sarici SU, Sari E, Gok F: Oral-ibuprofen-induced acute renal failure in a preterm infant. Pediatr Nephrol 2008; 23: 1565-1567.
9. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D: Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011; 128: 1618-1621.
10. Oncel MY, Yurttutan S, Uras N, Altug N, Ozdemir R, Ekmen S, Erdeve O, Dilmen U: An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed 2012, E-pub ahead of print.
11. Skinner J: Diagnosis of patent ductus arteriosus. Semin Neonatol 2001; 6: 49-61.
12. Singla NK, Parulan C, Samson R, Hutchinson J, Bushnell R, Beja EG, Ang R, Royal MA: Plasma and cerebrospinal fluid pharmacokinetic parameters after single-dose administration of intravenous, oral, or rectal acetaminophen. Pain Pract 2012; 12: 523-532.
13. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB: Case records of the Massachusetts General Hospital: laboratory values. N Engl J Med 2004; 35: 1549-1563.
14. Grèen K, Drvota V, Vesterqvist O: Pronounced reduction of in vivo prostacyclin synthesis in humans by paracetamol. Prostaglandins 1989; 37: 311-315.
15. Momma K, Takao A: Transplacental cardiovascular effects of four popular analgesics in rats. Am J Obstet Gynecol 1990; 162: 1304-1310.
16. Simbi KA, Secchieri S, Rinaldo M, Demi M, Zanardo V: In utero ductal closure following near-term maternal self-medication with nimesulide and acetaminophen. J Obstet Gynaecol 2002; 22: 440-445.